You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-Sars-COV-2 plasma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Milwaukee (anti-SARS-CoV-2 convalescent plasma)

Completed
  • COVID-19
  • anti-SARS-CoV-2 convalescent plasma
  • Milwaukee, Wisconsin
    Froedtert Hospital
Aug 23, 2022

COVID-19 Trial in Panama (Multiple doses of anti-SARS-CoV-2 Convalescent Plasma)

Completed
  • COVID-19
  • Multiple doses of anti-SARS-CoV-2 Convalescent Plasma
  • Panama, Panama
    1. Complejo Hospitalario Metropolitano Arnulfo Arias Madrid, Caj
Oct 24, 2022

Covid-19, Sars-CoV2 Trial in Los Angeles, Baltimore (Multiple Doses of Anti-SARS-CoV-2 convalescent plasma)

Terminated
  • Covid-19
  • Sars-CoV2
  • Multiple Doses of Anti-SARS-CoV-2 convalescent plasma
  • Los Angeles, California
  • +1 more
Nov 1, 2021

COVID Trial in Stony Brook (Convalescent Plasma, Standard Donor Plasma)

Terminated
Has Results
  • COVID
  • Convalescent Plasma
  • Standard Donor Plasma
  • Stony Brook, New York
    Stony Brook University Hospital
Dec 2, 2021

SARS-CoV-2 Infection Trial in Baltimore (Anti-SARS-CoV-2 Human Convalescent Plasma)

Completed
  • SARS-CoV-2 Infection
  • Anti-SARS-CoV-2 Human Convalescent Plasma
  • Baltimore, Maryland
    Johns Hopkins Hospitals
Dec 14, 2021

Effect of SARS-CoV-2 Vaccination in Liver Transplant Recipients

Completed
  • SARS-CoV-2 Vaccination
  • Liver Transplantation
  • Immunoassay, by ECLIA, for the quantitative in vitro determination of antibodies (including IgG) to the SARS - CoV - 2 spike protein (S) anti-RBD (receptor-binding domain) in serum and plasma samples.
  • Roma, Italy
    Policlinico Tor Vergata
Aug 3, 2022

COVID-19 Trial in Bruxelles (Evolution of antibodies titre)

Recruiting
  • COVID-19
  • Evolution of antibodies titre
  • Bruxelles, International, Belgium
    Cliniques universitaires Saint-Luc
Jan 12, 2022

Coronavirus, Convalescence Trial in United States (Anti- SARS-CoV-2 Plasma, SARS-CoV-2 non-immune Plasma)

Completed
Has Results
  • Coronavirus
  • Convalescence
  • Anti- SARS-CoV-2 Plasma
  • SARS-CoV-2 non-immune Plasma
  • Birmingham, Alabama
  • +24 more
Apr 22, 2022

SARS-CoV-2 Infection Trial in New York, Rio De Janeiro (Convalescent Plasma (anti-SARS-CoV-2 plasma), Non-convalescent Plasma

Completed
  • SARS-CoV-2 Infection
  • Convalescent Plasma (anti-SARS-CoV-2 plasma)
  • Non-convalescent Plasma (control plasma)
  • New York, New York
  • +3 more
May 16, 2021

COVID, Corona Virus Infection, Viral Pneumonia Trial in Denmark (Convalescent anti-SARS-CoV-2 plasma, Infusion )

Terminated
  • COVID
  • +2 more
  • Convalescent anti-SARS-CoV-2 plasma
  • Infusion placebo
  • Aalborg, Denmark
  • +11 more
Aug 2, 2022

COVID-19, Coronavirus, Coronavirus Infection Trial in United States (Convalescent Plasma, Saline solution)

Active, not recruiting
Has Results
  • COVID-19
  • +2 more
  • Convalescent Plasma
  • Saline solution
  • New Haven, Connecticut
  • +8 more
Mar 30, 2022

COVID-19 Trial (anti-SARS-CoV-2 plasma, Placebo)

Withdrawn
  • COVID-19
  • anti-SARS-CoV-2 plasma
  • Placebo
  • (no location specified)
Oct 20, 2020

SARS-CoV-2 Infection, Safety and Efficacy Trial in Spain (Convalescent anti-SARS-CoV-2 MBT plasma, Control Group)

Completed
  • SARS-CoV-2 Infection
  • Safety and Efficacy
  • Convalescent anti-SARS-CoV-2 MBT plasma
  • Control Group
  • Badalona, Barcelona, Spain
  • +3 more
Sep 4, 2021

Covid-19 Trial in Mexico City (Anti SARS-CoV 2 Convalescent Plasma in severe COVID-19 patients, Anti SARS-CoV 2 Convalescent

Terminated
  • Covid-19
  • Anti SARS-CoV 2 Convalescent Plasma in severe COVID-19 patients
  • Anti SARS-CoV 2 Convalescent Plasma in critical COVID-19 patients
  • Mexico City, Mexico
    Centro Medico Abc
Jul 30, 2021

COVID-19 Trial in Chapel Hill (High-titer Convalescent COVID-19 Plasma (CCP1), Standard-titer Convalescent COVID-19 plasma

Completed
Has Results
  • COVID-19
  • High-titer Convalescent COVID-19 Plasma (CCP1)
  • Standard-titer Convalescent COVID-19 plasma (CCP2)
  • Chapel Hill, North Carolina
    University of North Carolina Health Care
Dec 1, 2021

Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Worldwide (Anti-Sars-CoV-2 Convalescent Plasma)

No longer available
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • Anti-Sars-CoV-2 Convalescent Plasma
  • Oceanside, California
  • +37 more
Feb 16, 2022

Collection of Anti-SARS-CoV-2 Immune Plasma

Completed
  • Coronavirus Disease 2019 (COVID-19)
    • Torrance, California
    • +2 more
    Mar 3, 2021

    Sars-Covid-19 Vaccines in Haematological Patients: Prospective

    Completed
    • Hematologic Diseases
    • IgG antibodies to Sars-Cov-2
    • QuantiFERON SARS-CoV-2 test
    • Monza, Lombardia, Italy
      San Gerardo Hospital
    Jan 23, 2023

    COVID-19, SARS CoV 2 Infection Trial in Orléans (Collection of biological samples)

    Not yet recruiting
    • COVID-19
    • SARS CoV 2 Infection
    • Collection of biological samples
    • Orléans, France
      Centre Hospitalier Régional d'Orléans, France
    Jul 21, 2022

    COVID 19 Trial in Budapest (anti-SARS-CoV-2 convalescent plasma)

    Unknown status
    • COVID 19
    • anti-SARS-CoV-2 convalescent plasma
    • Budapest, Hungary
      Semmelweis University's Department of Pulmonology
    Feb 23, 2021

    COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,

    Suspended
    • COVID-19 Infection
    • +2 more
    • Questionnaire Administration
    • Sotrovimab
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 24, 2023

    COVID-19 Trial in Beijing, Shanghai (Recombinant Human Anti-SARS-CoV-2 Monoclonal Antibody(25mg/kg;50mg/kg;100mg/kg), Placebo)

    Completed
    • COVID-19
    • Recombinant Human Anti-SARS-CoV-2 Monoclonal Antibody(25mg/kg;50mg/kg;100mg/kg)
    • Placebo
    • Beijing, China
    • +1 more
    Jul 14, 2022

    COVID-19: SARS-CoV-2-CZ-PREVAL-II Study

    Completed
    • COVID-19
    • SARS-CoV-2 Infection
    • Quantitative analysis of SARS-CoV-2 antibodies
    • Cellular immunity
    • Prague, Czechia
      Institute of Health Information and Statistics of the Czech Repu
    Nov 25, 2022

    Seroprevalence of Anti-SARS-CoV-2 Antibodies in Kidney

    Completed
    • COVID-19 Pandemic
    • Transplantation, Kidney
    • No intervention
    • Ostrava, Czechia
      University Hospital Ostrava
    Dec 6, 2022

    Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster

    Terminated
    • Anti-SARS-CoV-2 Antibody Response
    • blood and saliva samples will be taken
    • Graz, Austria
      Medizinische Universität Graz, Klinische Abteilung für Rheumatol
    Jan 9, 2023